Abstract 3-Iodothyronamine (T 1 AM) is an endogenous relative of thyroid hormone with profound metabolic effects. In different experimental models, T 1 AM increased blood glucose, and it is not clear whether this effect is entirely accounted by changes in insulin and/or glucagone secretion. Thus, in the present work, we investigated the uptake of T 1 AM by hepatocytes, which was compared with the uptake of thyroid hormones, and the effects of T 1 AM on hepatic glucose and ketone body production. Two different experimental models were used: HepG2 cells and perfused rat liver. Thyronines and thyronamines (T0AMs) were significantly taken up by hepatocytes. In HepG2 cells exposed to 1 mM T 1 AM, at the steady state, the cellular concentration of T 1 AM exceeded the medium concentration by six-to eightfold. Similar accumulation occurred with 3,5,3 0 -triiodothyronine and thyroxine. Liver experiments confirmed significant T 1 AM uptake. T 1 AM was partly catabolized and the major catabolites were 3-iodothyroacetic acid (TA1) (in HepG2 cells) and T0AM (in liver). In both preparations, infusion with 1 mM T 1 AM produced a significant increase in glucose production, if adequate gluconeogenetic substrates were provided. This effect was dampened at higher concentration (10 mM) or in the presence of the amine oxidase inhibitor iproniazid, while TA1 was ineffective, suggesting that T 1 AM may have a direct gluconeogenetic effect. Ketone body release was significantly increased in liver, while variable results were obtained in HepG2 cells incubated with gluconeogenetic substrates. These findings are consistent with the stimulation of fatty acid catabolism, and a shift of pyruvate toward gluconeogenesis. Notably, these effects are independent from hormonal changes and might have physiological and pathophysiological importance.
Introduction 3-Iodothyronamine (T 1 AM) is an endogenous relative of thyroid hormone, which is able to produce acute functional effects (Scanlan et al. 2004 , Piehl et al. 2011 . Recent advances in the quantitative analysis of T 1 AM using methods based on HPLC coupled to tandem mass spectrometry (MS/MS) have shown that T 1 AM can be detected in blood and tissues derived from rodents and humans, and that in several rat tissues, including heart, patients treated with T 4 provided evidence for extrathyroidal T 1 AM production, and limited T 1 AM formation was observed in cardiomyocytes incubated with T 3 (Saba et al. 2010) . On the other hand, a recent study has revealed that T 1 AM is not an extrathyroidal metabolite of T 4 , and is produced by a process that requires the same biosynthetic factors necessary for T 4 synthesis, namely the sodium-iodide symporter and thyroperoxidase .
The molecular target(s) of T 1 AM are largely unknown. In vitro studies provided evidence that T 1 AM can activate with high-affinity G protein-coupled receptors, including trace amine-associated receptor 1 (Scanlan et al. 2004 , Zucchi et al. 2006 ) and possibly a2-adrenoceptors (Regard et al. 2007) . In addition to these receptors, T 1 AM also interacts with plasma membrane and vesicular biogenic amine transporters (Snead et al. 2007 ) as well as different mitochondrial targets (Venditti et al. 2011 , Cumero et al. 2012 .
Administration of exogenous T 1 AM and other thyronamines (T0AMs) produced functional effects that showed a rapid onset and were often opposite to those induced by T 3 (Liggett 2004 , Weatherman 2007 . In rodents, i.p. T 1 AM injection rapidly induced hypothermia, decreased cardiac function and decreased the respiratory quotient, suggesting a shift from primarily carbohydrate to predominantly lipid utilization (Scanlan et al. 2004 , Chiellini et al. 2007 , Braulke et al. 2008 . Recent results from NMR-based metabolomics and breath studies have shown that chronic T 1 AM exposure induced a rapid increase in lipid mobilization, followed after a few days by increased protein breakdown (Haviland et al. 2013) . T 1 AM-treated mice showed continued reduction in body weight, independent of food consumption, and after T 1 AM withdrawal they regained only 1.8% of the lost weight in the following 2 weeks. Intracerebroventricular (i.c.v.) injection of T 1 AM modified hormone secretion, food intake, and memory acquisition (Dhillo et al. 2009 , Klieverik et al. 2009 , Manni et al. 2012 .
T 1 AM effects were not linearly related to the dosage and depended on the animal species and administration route (Dhillo et al. 2009 , Klieverik et al. 2009 , Manni et al. 2012 . The response to T 1 AM may also be affected by its complex metabolism, which includes oxidative deamination (to 3-iodothyroacetic acid, TA1), deiodination (to T0AM), sulfation (to O-sulfonate-T 1 AM), acetylation (to N-acetyl-T 1 AM), and glucuronidation (to T 1 AM-glucuronide) (Wood et al. 2009 .
Among its metabolic effects, T 1 AM has been reported to produce hyperglycemia (Regard et al. 2007 , Klieverik et al. 2009 ). Notably, hyperglycemia occurs after administration of relatively low doses of exogenous T 1 AM, producing changes in tissue concentration of about one order of magnitude (Manni et al. 2013 ). In addition a clinical investigation performed in a small series of patients revealed that serum T 1 AM concentration was significantly correlated with HbAlc, and significantly increased in a subgroup of diabetic patients (Galli et al. 2012) . Therefore, the effects of T 1 AM on glucose metabolism might have physiological and pathophysiological relevance. The mechanism of this effect is largely unknown. As hyperglycemia was observed after i.c.v. injection, it was originally attributed to central regulation of endocrine function, namely stimulation of glucagon secretion and/or inhibition of insulin secretion (Klieverik et al. 2009 ). However, it was recently observed that even after i.c.v. injection, a significant increase in plasma T 1 AM was produced (Manni et al. 2012) , and the possible occurrence of peripheral effects on glucose metabolism has been suggested. Because of the central role of liver in glucose homeostasis, the aim of the present work was to establish whether T 1 AM affects glucose metabolism in perfused liver and in a hepatocellular carcinoma cell line (HepG2 cells). An additional aim was to determine the uptake and metabolism of T 1 AM in the same preparations.
were seeded into 24-well plates (8.5!10 4 cells/well) and grown to 80% confluence. At the start of each experiment, the culture medium was removed and replaced with 0.5 ml of Krebs-Ringer medium (118 mM NaCl, 25 mM NaHCO 3 , 4.5 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 1.5 mM CaCl 2 , 1 g/l glucose, pH 7.4) and preincubated in a humidified atmosphere of 5% CO 2 at 37 8C for 30 min. Incubation was initiated by quickly replacing the preincubation medium with 0.5 ml Krebs-Ringer buffer, containing one of the following compounds: T 1 AM, T 3 , T 4 at 1 mM concentration. For each of the tested compound, a 1 mM stock solution in DMSO was previously prepared. The plate was returned to a humidified atmosphere of 5% CO 2 at 37 8C, the medium was removed from each well at specific time points (5 min to 24 h), centrifuged (11 600 g for 2-3 min) to eliminate detached cells, and analyzed by HPLC-MS/MS analysis. The cell plates were then frozen for 24-48 h and lysed in 0.1 ml 0.1 M NaOH. After pH neutralization (0.01 ml 1.0 N HCl), the cell lysates were diluted with Krebs-Ringer to a final volume of 0.5 ml, centrifuged at 5000 g for 10 min, and used for HPLC-MS/MS analysis. As assessed in previous experiments, where cells were removed from the well by scraping in the presence of ice-cold PBS followed by centrifugation at 5000 g for 10 min, the packed cell volume was on the order of 0.02 ml. Therefore, we can assume that during cell lysates preparation (0.5 ml, final volume), the cellular content in the final sample was diluted by about 25-fold. Similar experiments were carried out to examine the effect of amine oxidase inhibitor, iproniazid, on T 1 AM metabolism. The cells were preincubated for 30 min with 0.5 ml Krebs-Ringer buffer supplemented with iproniazid (10 mM stock solution in DMSO to a final concentration of 100 mM) before adding T 1 AM.
To assess glucose and ketone body release, HepG2 were seeded into six-well plates (5!10 5 cells/well) and grown to 80% of confluence with standard medium. Before treatment, the cells were washed twice with PBS and then exposed for 4 h to exogenous T 1 AM (0.1, 0.5, 1, 5, and 10 mM) or TA1 (0.5 and 1 mM) in 1 ml DMEM base, glucose-and phenol red-free, containing 100 U/ml penicillin, 100 mg/ml streptomycin, and 4 mM L-glutamine, supplemented with 2 mM sodium pyruvate and 20 mM sodium lactate (glucose production buffer; Yoon et al. 2001) at 37 8C in 5% CO 2 . In some experiments, the amine oxidase inhibitor iproniazide (100 mM) was also included. Control cells were incubated with DMEM containing DMSO (10-20 ml/well).
To assess free fatty acid (FFA) release, HepG2 were exposed to exogenous 1 mM T 1 AM for four or 24 h in DMEM base (glucose-and phenol red-free), containing 100 U/ml penicillin, 100 mg/ml streptomycin, and 4 mM glutamine, supplemented with 1 g/l glucose and 1 mM sodium pyruvate.
To induce steatosis, HepG2 were exposed to exogenous lipids as described (Di Nunzio et al. 2011 , Yao et al. 2011 . Cells were incubated with 1 mM T 1 AM in DMEM base (glucose-and phenol red-free) containing 100 U/ml penicillin, 100 mg/ml streptomycin, 4 mM glutamine, 1 g/l glucose, 1 mM sodium pyruvate, and supplemented with 1 mM of FFA mixture (2:1 ratio of oleate and palmitate) in 1% BSA for 24 h (stock solution of 30 mM FFA was conveniently diluted to 1 mM in culture medium). In each experimental protocol, control cells were incubated with supplemented DMEM-containing DMSO.
Cell culture medium was then collected and glucose, ketone bodies (acetoacetate and 3-hydroxybutyrate), and fatty acid levels were evaluated.
Rat liver perfusion
This investigation conforms to the Declaration of Helsinki and the Guiding Principles in the Care and Use of Animals. The project was approved by the Animal Care and Use Committee of the University of Pisa.
Male Wistar rats (275-300 g body weight), fed a standard diet, were anesthetized with a mixture of ether and air and the livers were perfused in situ with glucosefree Krebs-Ringer buffer or glucose production buffer equilibrated with a mixture of O 2 (95%) and CO 2 (5%) at a constant flow rate of 10 ml/min. The fluid was introduced through a cannula inserted into the portal vein, while a second cannula inserted into the inferior cava vein was used to collect the effluent perfusate. After 10 min washout period and 10 min perfusion with KrebsRinger buffer alone, T 1 AM (1 mM or 50 nM) was added to the non-recirculating buffer, and the liver was perfused for another 40 min, followed by 10 min of perfusion with Krebs-Ringer buffer alone (Mario et al. 2009 ). In control experiments, liver was perfused for 60 min with KrebsRinger buffer alone. During the experiment, samples of the perfusion buffer were collected at 5 min intervals, and at the end of the experiments the liver was removed and frozen at K80 8C.
In the experiments to evaluate hormone up-take and metabolism, isolated rat liver was perfused with 50 nM or 1 mM T 4 , T 3 , or T 1 AM in Krebs-Ringer buffer, as described earlier, and tissue concentration was determined after 60 min. HPLC-MS/MS analysis that allowed the simultaneous detection of T 3 , T 4 , T 1 AM, and its putative metabolites, namely T0AM, TA0, and TA1, was carried out as described elsewhere (Saba et al. 2010) .
Metabolite assays
Glucose concentration was assessed in 100 ml of medium or perfusate with a colorimetric glucose assay kit (Sigma-Aldrich). Ketone bodies were evaluated in the medium or perfusate by enzymatic methods as elsewhere described (Alberti & Hockaday 1972) . Briefly, acetoacetate was determined in a reaction mix containing 0.05 mM K 2 HPO 4 (pH 7), 0.02% NADH, and 0.25 U/ml 3-hydroxybutyrate dehydrogenase. The mixture was incubated for 45 min at 30 8C and absorbance was read at 340 nm to evaluate NADH reduction. 3-Hydroxybutyrate was measured in a reaction mix containing 0.03 M Tris-HCl (pH 8.5), 2% hydrazine, 0.06% EDTA, 0.02% NAD, and 0.25 U/ml 3-hydroxybutyrate dehydrogenase. The mixture was incubated for 45 min at 30 8C and absorbance was read at 340 nm to evaluate NADH production.
Fatty acid concentration was determined in the cell culture medium with a FFA quantification kit (BioVision Research Product, Malpitas, CA, USA) upon extraction. Fatty acids were extracted by adding 200 ml of dichloromethane to 850 ml of medium. The mixture was vortexed and spinned at 10 000 g for 5 min. The organic phase was collected and vacuum dried for 1 h to remove dichloromethane. Dried lipids were then dissolved in 50 ml of assay buffer provided by the kit and used for the assay.
Metabolite concentrations were referred to the total protein content (Bradford 1976 ) of whole-cell lysates (in HepG2 experiments) or to wet tissue weight (in liver experiments). experiments carried out in the presence of 100 mM iproniazid. Assays were performed at different time in the incubation medium and in the cell lysate. During preparation, the lysate was diluted w20-to 25-fold to a final volume of 500 ml.
Statistical analysis
Results are expressed as the meanGS.E.M. Differences between groups were analyzed by ANOVA or, when only two groups were involved, by unpaired t-test. Regression analysis was performed by linear, exponential, or hyperbolic models, as detailed in the description of each experiment. The threshold of statistical significance was set at P!0.05. GraphPad Prism version 6.0 for Windows (GraphPad Software, San Diego, CA, USA) was used for data processing and statistical analysis.
Results

T 1 AM uptake and catabolism in HepG2 cells and in perfused rat liver
When cells were exposed to 1 mM T 1 AM, its concentration in the incubation medium decreased exponentially, while lysate T 1 AM increased, reaching a steady state after about 10 min (Fig. 1A) . In these experiments, incubation medium volume was 500 ml, while the original volume of cell lysate was on the order of 20-25 ml, and the latter was diluted to a final volume of 500 ml to facilitate processing and assay. Steady-state concentrations were close to 500 and 150 nM in the incubation medium and in diluted cell lysate respectively (Fig. 1A) . Taking into account the dilution factor, the actual steady-state cellular concentration can be estimated to average about 3-4 mM, exceeding medium concentration by over six-to eightfold. The overall recovery of T 1 AM was on the order of 65-70% (500 pmol were added and the final amounts detected in incubation medium and in cell lysate averaged w250 and 75 pmol respectively).
T 1 AM adhesion to cell culture plates, as determined by carrying out the experiment in the absence of cells, was limited, accounting only for about 10% decrease in T 1 AM concentration. Additional experiments were also carried out at 4 8C, and the rate constant of the exponential decay decreased from 0.052G0.006/min to 0.025G0.004/min (P!0.01), suggesting that active biochemical process are involved in this phenomenon.
Medium and lysate were also assayed for T 1 AM catabolites. TA1 accumulated over time both in lysate and in medium, reaching a concentration of about 140 nM in both compartments after 240 min (due to lysate dilution, this corresponds to an estimated cellular concentration of 2.8-3.5 mM). T0AM was detected at very low concentration (!0.5 nM) (Fig. 1B) , while TA0 was not revealed (data not shown). Overall catabolite production accounted for about 30% of T 1 AM administration.
Experiments were repeated in the presence of the amine oxidase inhibitor iproniazid, and in these conditions T 1 AM recovery averaged 99%, because after 240 min incubation medium and lysate concentrations averaged 700 and 300 nM, respectively, while TA1 production was almost abolished (Fig. 1C) and T0AM was not significantly modified (data not shown).
By comparison, similar experiments were performed by incubating HepG2 cells with T 3 or T 4 . As observed with T 1 AM, lysate concentrations increased while medium concentrations decreased exponentially, until a steady state was obtained after about 120 min. At the steady state, medium concentrations averaged 651G73 and 413G 91 nM for T 3 and T 4 respectively. The corresponding lysate concentrations were 135G59 and 343G137 nM respectively. The overall recovery was close to 80% for T 3 and T 4 . T 1 AM, T 3 , and T 4 uptake were also investigated in perfused rat liver. After 40 min of perfusion with 50 nM or 1 mM T 1 AM, tissue concentration averaged 87.2G22.0 and 1013.8G312.5 pmol/g, respectively, vs a control value of 7.1G4.2 pmol/g. Among putative catabolites, only T0AM was detected in the liver homogenate at concentrations approximately one order of magnitude lower than T 1 AM. In this model, T 1 AM uptake was lower than T 3 and T 4 uptake, because after 40 min of perfusion with 50 nM T 3 or T 4 their tissue concentrations averaged 853.6 and 1531.2 pmol/g, respectively, vs control values of 3.9 and 15.5 pmol/g. If perfusate T 3 and T 4 concentrations were raised to 1 mM, tissue concentrations after 40 min of perfusion averaged 2.14 and 3.90 mmol/g respectively. In the latter experiments, the assay of T 3 and T 4 in the perfusion buffer confirmed that over 90% of infused hormones were taken up and stored in the tissue.
Notably, perfusion with T 3 or T 4 was not associated with significant increase in tissue T 1 AM, nor was perfusion with T 1 AM was not associated with any significant change in tissue T 3 or T 4 (data not shown).
Metabolite assays
In HepG2 cells cultured in glucose production buffer ( Fig. 2A) , incubation with 1 mM T 1 AM induced w25% increase in glucose production (P!0.01). In other experiments, the dose dependence of this effect was investigated (Fig. 2B) : the estimated EC 50 was 0.84 mM, but at 5 or 10 mM T 1 AM the stimulation of glucose production decreased, yielding a bell-shaped dose-response curve.
More complex findings were obtained with regard to ketone body production. Baseline ketone body production and the response to T 1 AM apparently depended on the number of passages performed in vitro. Using cells which underwent O30 passages in vitro, treatment with 1 mM T 1 AM produced a slight (11%) but significant decrease in ketone body release (Fig. 2C) , chiefly accounted for by decreased acetoacetate release (252.4G10.5 vs 286.8G 7.2 nmol/mg protein, P!0.05), while no significant effect was detected using 0.1 or 10 mM T 1 AM (data not shown). However, when we took care to use cells that underwent no more than 20 passages, we observed that baseline ketone body production was higher (on the order of 630 nmol/mg proteins), and under these conditions T 1 AM produced a dose-dependent stimulation of ketone body release, with EC 50 on the order of 1.12 mM (Fig. 2D ).
In the presence of 100 mM iproniazid, the increase in glucose production induced by 1 mM T 1 AM was dampened (9%) and did not reach the threshold of statistical significance (5.99G0.17 vs 6.53G0.31 mg/mg protein in cell lysate, PZNS). We also tested the effect of TA1, the major T 1 AM catabolite, and, at 500 nM or 1 mM concentration, it did not affect either glucose or ketone body release. Notably, cellular uptake of TA1 was substantially lower than that observed with T 1 AM (15 vs 60%).
In the presence of exogenous glucose, T 1 AM did not produce any change in fatty acid production after 4 or 24 h of incubation (Fig. 3A and B) , although at the later time point there was a slight increase that did not reach the threshold of statistical significance (PZ0.088). Under conditions promoting steatosis, i.e. with supplementation of exogenous glucose and fatty acid mixture, after 24 h T 1 AM did not affect FFA concentration, while glucose concentration was increased (P!0.01), suggesting increased production and/or decreased consumption ( Fig. 4A and B) .
Liver perfusion with glucose production buffer in the presence of 1 mM T 1 AM (Fig. 5 ) also showed a significant increase in glucose production ( Fig. 5A , P!0.05) that was associated with increased ketone body release ( Free fatty acid (FFA) production in HepG2 cell cultures that were incubated for 4 h (A) or 24 h (B) in DMEM medium as described in Materials and methods. Results are expressed as meanGS.E.M. of nine biological replicates and are normalized to the total cell protein content determined in cell lysates. Differences between groups were not statistically significant (unpaired t-test).
3-hydroxybutyrate release (246.0G21.04 vs 153.3G 11.81 nmol/min per g, P!0.01).
Infusion with Krebs-Ringer buffer did not produce any significant change in metabolite release (glucose: 0.24G0.17 vs 0.29G0.02 mg/min per g, PZNS; ketone bodies 40.1G4.9 vs 35.1G3.0 nmol/min per g, nZ8-9). A few experiments (nZ2) were also carried out in livers obtained from 4 h fasted rats, and a 26% increase in the release of ketone bodies was observed (231G22 vs 175G 25 nmol/min per g), while glucose release was not affected (0.28G0.06 vs 0.28G0.05 mg/min per g).
Discussion
In this investigation, we observed that T 1 AM, such as T 3 and T 4 , can be taken up and accumulated in hepatocytes. In HepG2 cell culture, these compounds were quickly absorbed because their presence was detected in cell lysate after a few minutes of infusion. At the steady state, estimated cellular concentration exceeded medium concentration by about six-to eightfold. These results are in agreement with previous observations performed in cardiomyocytes (Saba et al. 2010 ) and in FRTL-5 thyroid cells (Agretti et al. 2011) , and they are consistent with the results obtained in perfused liver, where tissue concentration was higher than perfusate concentration. In this model, the ratio between tissue and perfusate concentration was lower than the lysate:medium ratio observed in cell cultures, but it should be considered that T 1 AM is likely to be taken up and catabolized by vascular and interstitial cells, and that it undergoes biliary excretion .
In HepG2 cells, T 1 AM recovery was on the order of 70%. Most of the balance was accounted for by oxidative deamination, yielding the thyroacetic derivative TA1 that was detectable in cell lysate and medium within a few minutes. Although D1 deiodinase has been reported to be expressed in HepG2 cells (Jakobs et al. 2002) , T0AM production was minimal, probably because of the absence of D3 deiodinase and/or of essential cofactors for deiodination or decarboxylation, while it was greater in perfused liver, where it appears to be more relevant than oxidative deamination. We cannot, however, exclude that additional metabolic pathways may be active, particularly conjugation to sulfate and glucuronide , because the corresponding derivatives could not be tested by the present method. Glucose (A) and ketone body (KB) (B) release by livers perfused with 1 mM T 1 AM in glucose production buffer. Glucose and KB concentrations were determined in the perfusate every 5 min for a total period of 40 min, and the average release rate was calculated, as described in Materials and methods. Results are expressed as meanGS.E.M. of the three experiments and are normalized to tissue wet weight. **P!0.01 by unpaired t-test.
It should be stressed that about 50% of administered T 1 AM, T 3 , or T 4 , was detected in cell lysate after 2 h of infusion. As a consequence at the steady state the estimated cellular concentration of T 3 , T 4 , and T 1 AM was significantly higher than medium concentration. This suggests the existence of specific binding sites and/or transport pathways for T 1 AM and thyroid hormones.
The molecular mechanism by which T0AMs are taken up is still controversial. Eight potential transporters belonging to the solute carrier family have been tentatively identified (Ianculescu et al. 2009 ), although their affinity and sodium-independence did not seem to be consistent with the characteristics of T 1 AM uptake (Saba et al. 2010) . Recently it has been reported that T 1 AM is largely bound to apolipoprotein B-100 (apo-B100), the protein component of LDLs (Roy et al. 2012) . This could be a potential vehicle to transport T 1 AM and other T0AMs into cells which expressed the receptor for LDL, even though this is unlikely to contribute to our results, because in our experiments the standard growth medium supplemented with fetal bovine serum was replaced with other media, namely Krebs buffer or glucose production buffer, which do not contain lipoproteins. In any case, the kinetics of T 1 AM removal from the incubation medium was significantly lower at 4 8C, suggesting the presence of active transport mechanisms.
The primary aim of this work was to establish whether T 1 AM may directly stimulate hepatic glucose production. If adequate substrates for gluconeogenesis were provided, T 1 AM increased glucose production in two different experimental models, namely cultured HepG2 cells and in situ perfused rat liver. So consistent results were obtained in different experimental models, which also investigate different time scales, because the former was a subchronic and the latter an acute model. We conclude that modulation of hepatic metabolism may contribute to the hyperglycemic effect reported after administration of exogenous T 1 AM (Regard et al. 2007 , Klieverik et al. 2009 , Manni et al. 2012 , which had previously been attributed only to modulation of insulin and/or glucagone secretion.
In HepG2 cells, the EC 50 for the effect on gluconeogenesis was in the submicromolar range, and in perfused liver experiments a significant effect was observed with infusion of 1 mM T 1 AM, resulting in tissue concentration on the order of 1000 pmol/g. It is not easy to discuss the potential physiological relevance of these observations, as there is still some uncertainty about the physiological levels of T 1 AM. In humans, using an immunological assay , the plasma concentrations were reported on the order of 66 nM, while plasma T 1 AM concentration measured by a mass spectrometry-based assay was about 200-fold lower (Galli et al. 2012) . As T 1 AM binds with high affinity to apo-B100 (Roy et al. 2012) , it has been hypothesized that these different techniques estimate total and free T 1 AM respectively. However, T 1 AM is known to be concentrated in tissues, as discussed above, and we have previously reported that its liver content in rat in vivo was on the order of 90 pmol/g (Saba et al. 2010 ). If we rely on this value, then we may suggest that infusion of exogenous 1 mM T 1 AM raised liver concentration to a value that was one order of magnitude greater than the physiological concentration, after the depletion presumably occurring during prolonged perfusion with T 1 AM-free buffer (after over 60 min of perfusion 'control' values were close to 1 pmol/g). Further experiments will be necessary to clarify these important issues.
The effect of T 1 AM on gluconeogenesis may show a bell-shaped dose-response curve, because the response of HepG2 was reduced at the highest concentration tested (10 mM). This is not surprising, because other functional effects of T 1 AM, particularly on feeding and behavior, are also biphasic (Dhillo et al. 2009 , Hettinger et al. 2010 , Manni et al. 2012 . Consistent with this interpretation, the response to 1 mM T 1 AM decreased in the presence of iproniazid, which inhibits its deamination to TA1, while we did not obtain any significant response after administration of exogenous TA1, whose cellular uptake was very low.
Another effect attributed to T 1 AM is the stimulation of lipid catabolism, with a shift from glucose to fatty acid as energy source (Braulke et al. 2008 , Haviland et al. 2013 . We observed a similar effect in the perfused liver model, because T 1 AM induced an increase in the release of ketone bodies. The results obtained in the HepG2 model were more complex, and in a subset of cells showing low values of baseline ketone body production T 1 AM reduced ketogenesis.
The different timing of these two experimental models might partly account for this discrepancy, because in the conscious mouse T 1 AM-induced stimulation of lipid catabolism was also time dependent (Haviland et al. 2013) . Alternatively, it might be suggested that energy production by HepG2 cells, which are known to have limited ketogenic capability (Vilà-Brau et al. 2011) , may be significantly dependent on pyruvate and amino acid catabolism, so that pyruvate shift toward gluconeogenesis would cause less acetyl-CoA to be available for ketogenesis. Notably, in HepG2 cells no significant effect was apparent on fatty acid production.
In conclusion, we observed that T 1 AM is actively accumulated in hepatocytes, where at concentrations in the micromolar range it is able to stimulate gluconeogenesis and to stimulate ketogenesis, provided that adequate energy substrates are available. These effects are independent from hormonal changes and might have physiological and pathophysiological importance. It would also been interesting to investigate whether T 1 AM may contribute to the metabolic effects usually attributed to thyroid hormone and/or to the metabolic abnormalities observed in hypothyroidism, a condition in which tissue and plasma T 1 AM levels have been reported to be decreased (Galli et al. 2012 ).
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